microarray scanner (Danaher Inc)
Danaher Inc is a verified supplier 
Danaher Inc manufactures this product 
94
Structured Review
Danaher Inc
microarray scanner
Microarray Scanner, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 94/100, based on 461 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+scanner+system/GenePix+Microarray+Systems/pm42772593-192-17-19
Average 94 stars, based on 461 article reviews
Microarray Scanner, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 94/100, based on 461 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+scanner+system/GenePix+Microarray+Systems/pm42772593-192-17-19
Average 94 stars, based on 461 article reviews
microarray scanner - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Fluorescence:Article Title: Profiling the HCV Immune Response in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma by Peptide Microarray Analysis. Article Snippet: Background: Chronic infection with hepatitis C virus (HCV) is among the major causes of hepatic fibrosis, cirrhosis, as well as hepatocellular carcinoma (HCC), and it is associated with a significant risk of developing lymphoproliferative disorders.. The rate of clinical disease progression is variable depending on multiple host and viral factors, including immune response.. Methods: To perform a comprehensive epitope mapping of anti-HCV antibodies in patients suffering from HCV-related liver or lymphoproliferative diseases, we analyzed clinical samples on a peptide microarray platform made of 5952 overlapping 15-mer synthetic peptides derived from the whole HCV proteome. Imaging:Article Title: Profiling the HCV Immune Response in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma by Peptide Microarray Analysis. Article Snippet: Background: Chronic infection with hepatitis C virus (HCV) is among the major causes of hepatic fibrosis, cirrhosis, as well as hepatocellular carcinoma (HCC), and it is associated with a significant risk of developing lymphoproliferative disorders.. The rate of clinical disease progression is variable depending on multiple host and viral factors, including immune response.. Methods: To perform a comprehensive epitope mapping of anti-HCV antibodies in patients suffering from HCV-related liver or lymphoproliferative diseases, we analyzed clinical samples on a peptide microarray platform made of 5952 overlapping 15-mer synthetic peptides derived from the whole HCV proteome. Microarray:Article Title: Profiling the HCV Immune Response in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma by Peptide Microarray Analysis. Article Snippet: Background: Chronic infection with hepatitis C virus (HCV) is among the major causes of hepatic fibrosis, cirrhosis, as well as hepatocellular carcinoma (HCC), and it is associated with a significant risk of developing lymphoproliferative disorders.. The rate of clinical disease progression is variable depending on multiple host and viral factors, including immune response.. Methods: To perform a comprehensive epitope mapping of anti-HCV antibodies in patients suffering from HCV-related liver or lymphoproliferative diseases, we analyzed clinical samples on a peptide microarray platform made of 5952 overlapping 15-mer synthetic peptides derived from the whole HCV proteome. |